MarketInOut Stock Screener Log In | Sign Up
 

Pulmonx Corp

NASDAQ • Healthcare • Medical Devices • Quote as of 10/23/2026
Pulmonx Corp stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization79.41 mln
Float38.45 mln
Earnings Date10/27/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-3.25
Reliable

Relative Strength

58 / 100
Slightly ahead

Debt / Equity

1.43
Elevated leverage

Pre-Tax Margin

-54%
Severely loss-making

ROE

-89.70
Deeply negative

Business Description

Pulmonx Corporation develops and sells minimally invasive medical tools designed to help patients living with severe emphysema, a serious lung condition. Its core product, the Zephyr Endobronchial Valve, works alongside diagnostic tools that help doctors evaluate lung function and identify the best areas for treatment. The company also provides a cloud-based imaging service that gives physicians detailed information about lung health to support better treatment planning. Founded in 1995 and based in Redwood City, California, Pulmonx serves patients across the United States and in markets spanning Europe, the Middle East, Africa, and Asia Pacific.

Key Fundamentals

EPS-1.15
ROE-89.70
RPS2.10
ROIC-89.66
ROA-36.78
Interest Cover-12.29
EBITDA, mln-42.53
EV / EBITDA-1.92
EV / EBIT-1.86
Revenue, mln87.44
EV / Revenue0.93

Quote Details

Last 1.83
Change -0.05 (-2.66%)
Open 1.80
Volume 227,761
Turnover 416,803
Average Volume 269,273

Financial Ratios

Pre-Tax Profit Margin-54
Leverage Ratio2.93
Current Ratio4.32
Price / Book2.10
Price / Tangible Book2.22
Debt / Equity1.43
Price / Sales0.94

Financial Strength

Altman Z-Score-5.77
Piotroski F-Score 4 / 9
Beneish M-Score-3.25
Short Ratio2.70
Short % of Float2.21

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 2.81% 82 / 100   
1 Month -3.68% 44 / 100   
2 Months 34.56% 96 / 100   
6 Months 44.09% 95 / 100   
1 Year 14.38% 73 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog